These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 582744)

  • 1. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the bioavailability of phenytoin.
    Neuvonen PJ; Pentikäinen PJ; Elfving SM
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):84-9. PubMed ID: 577918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bio-availability of phenytoin free-acid serum level determinations whilst using a lactose-based tablet-preparation (author's transl)].
    Fritsch G; Haidvogl M; Füger G; Urban C
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):648-50. PubMed ID: 6107823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 7. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bio-availability and dissolution of three phenytoin preparations for children.
    Hodges S; Forsythe WI; Gillies D; Remington H; Cawood A
    Dev Med Child Neurol; 1986 Dec; 28(6):708-12. PubMed ID: 3817309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of several phenytoin preparations marketed in Austria.
    Nitsche V; Mascher H; Schütz H
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):104-7. PubMed ID: 6698663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study.
    Suthisisang C; Payakachat N
    J Med Assoc Thai; 1998 Jan; 81(1):58-63. PubMed ID: 9470323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of relative humidity on drug release from phenytoin sodium tablets and capsules. Part 1: Commercial preparations.
    Akbuğa J; Ari-Ulubelen A; Bayraktar-Alpmen G
    Pharmazie; 1984 Aug; 39(8):560-1. PubMed ID: 6504981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of flufenamic acid and its dissolution rate from capsules.
    Kaniwa N; Ogata H; Aoyagi N; Shibazaki T; Ejima A; Watanabe Y; Motohashi K; Sasahara K; Nakajima E; Morioka T; Nitanai T
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):56-63. PubMed ID: 6840926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of phenytoin: a comparison between two preparations.
    Zylber-Katz E; Granit L; Levy M
    Isr J Med Sci; 1978 Apr; 14(4):489-91. PubMed ID: 352994
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS).
    Atef E; Belmonte AA
    Eur J Pharm Sci; 2008 Nov; 35(4):257-63. PubMed ID: 18706499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.